Related by context. All words. (Click for frequent words.) 64 Notified Bodies 61 Solvency II directive 61 biosimilar medicines 60 pharmaco vigilance 60 orphan medicinal 59 REACH Regulation 59 Centralized Procedure 59 Associations EFPIA 59 Solvency II Directive 58 Lamfalussy process 58 postmarket surveillance 58 ICH guidelines 58 GSK Avandia 58 Certican 57 directive #/#/EC [002] 57 ECVAM 57 commissioner Androulla Vassiliou 57 Barbara Helfferich spokeswoman 57 comitology procedure 57 EC Directive #/#/EC 57 Noxafil 57 EFPIA 57 Cosmetics Directive 56 Arranon 56 spokeswoman Antonia Mochan 56 Prepandrix 56 CONBRIZA 56 directive #/#/EC [001] 56 Neupro ® rotigotine 56 Postmarket 56 Forsteo 56 Diet Physical Activity 56 genetically modified organisms GMO 56 RISDP 56 Yondelis ® 56 Plasmin 56 SmPC 56 Colipa 56 #/#/CE 56 NICE guideline 56 postapproval 56 RoActemra 56 Batteries Directive 55 Marketing Authorization Applications 55 Directive #/#/EC [001] 55 Lambert Eaton Myasthenic 55 Euratom Treaty 55 comitology 55 Hexvix 55 GMO cultivation 55 Angiox ® 55 see Europolitics# 55 Proprietary Medicinal Products 54 Food Supplements Directive 54 Directive #/#/EEC [001] 54 FDAs 54 Sanofi Acomplia 54 EURODAC 54 GHTF 54 Aviptadil 54 AIFM Directive 54 Cintredekin besudotox 54 Eucomed 54 ECJ rulings 54 PDUFA reauthorization 54 Pharma Planta 54 Novel Foods 54 ERGEG 54 subsidiarity principle 54 MEMO/#/# [002] 54 Competent Authorities 54 Ethical Guidelines 54 Liability Directive 54 pulls Darvon painkiller 54 Directive #/#/EC [003] 54 Afatinib 54 Lofexidine 54 REACH Registration 54 Raptiva R 54 SNT MC# 54 TBBPA 54 EHPM 54 Mediation Directive 54 riociguat 54 TEMODAL 54 ICH GCP guidelines 54 Product Characteristics 54 Centralised Procedure 54 Pfizer inhaled insulin 54 nitrates directive 54 Circadin R 53 MIFID 53 genetically modified foodstuffs 53 SEBIVO 53 Timeshare Directive 53 Firazyr ® 53 Vasogen Celacade 53 Rasilamlo 53 Receives Marketing Authorization 53 Ceplene ® histamine dihydrochloride 53 WHO prequalification 53 FLUPAN 53 bioresearch monitoring 53 Serdolect ® 53 #/#/EC [001] 53 Lamfalussy 53 Öko Institut 53 MAAs 53 Decision #/#/EC 53 Directive #/#/EEC [002] 53 gene spliced foods 53 Traditional Herbal Medicinal Products 53 AZILECT ® 53 cGMPs 53 TRIPS flexibilities 53 EC Directives 53 Medicines Agency 53 biotechnological advances 53 European Pharmacopoeia 53 Framework Programmes 53 Directive #/#/EC [006] 53 spokeswoman Nina Papadoulaki 53 Neupro R 53 CPMP 53 Vimpat ® lacosamide 53 Erythropoiesis Stimulating Agents ESAs 53 Renewables Directive 53 Removab 53 MON# maize 53 Roaming Regulation 53 ePrivacy Directive 52 AIFMD 52 Increlex R 52 Seveso II 52 EU Framework Programmes 52 Sebivo 52 Gleevec Glivec 52 Operational Guidelines 52 PhotoCure 52 histamine dihydrochloride 52 Alvesco R 52 orphan designation 52 Tubercin R 52 Voraxaze 52 Chemicals REACH 52 Roche Xeloda 52 Orphan Drugs 52 Landfill Directive 52 Orphan Status 52 Olmesartan 52 Deposit Guarantee Schemes 52 spokesman Gerassimos Thomas 52 Vimpat R 52 ARIXTRA R 52 Viracept nelfinavir 52 DAPT Study 52 Allowances EUAs 52 darbepoetin alfa Aranesp 52 Developing Countries Clinical Trials 52 Directive #/#/EC [004] 52 StemEx R 52 ITRE 52 Copyright Directive 52 Hazardous Substances RoHS Directive 52 Framework Directive 52 Diamyd r vaccine 52 Remedies Directive 52 BfArM 52 Afssaps 52 STRIDE PD 52 Mimpara 52 ACOMPLIA R 52 Trovax 52 Fingolimod 52 SUTENT ® 52 Chemicals Agency ECHA 52 Habitats Directive 52 Slovenian Presidency 52 Subpart E 52 Hepatotoxicity 52 YONDELIS R 52 Mr Busquin 52 commissioner Markos Kyprianou 52 Non tariff barriers 52 Ruconest 52 Marketing Authorization 52 rimonabant Acomplia 52 ICH E# 52 Zebinix R 52 Nexavar tablets 52 commissioner Günter Verheugen 52 Intellectual Property Rights TRIPs 52 Genetically Modified Organisms GMOs 52 Retacrit 51 spokeswoman Mireille Thom 51 biogeneric 51 AstraZeneca Iressa 51 Directive #/#/CE 51 JTIs 51 #/#/EC [002] 51 Certolizumab pegol 51 sheep EID 51 Medicinal Products EMEA 51 EGTT 51 GLP GMP 51 Telzir 51 International Nonproprietary Name 51 MHRA 51 Luveris 51 biogeneric drugs 51 lobby BusinessEurope 51 Teysuno 51 ICH GCP 51 Marketing Authorisation 51 QbD 51 AIFM directive 51 Registration Evaluation Authorization 51 Fund Managers AIFM 51 erythropoietin stimulating agents 51 EPER 51 Combating Counterfeit Drugs 51 IADSA 51 Esbriet ® 51 commissioner Siim Kallas 51 RoACTEMRA 51 Lipid lowering 51 RoHS WEEE 51 CORDIS 51 UCB Cimzia 51 EU Roaming Regulation 51 Gender Directive 51 Plenaxis R 51 Antisoma AS# 51 obesity pill Acomplia 51 postmarketing surveillance 51 Privacy Directive 51 rotigotine transdermal patch 51 Machinery Directive 51 FIRAZYR 51 MHLW 51 Technical Barriers 51 Commissioner Figel 51 Zavesca 51 poststroke depression 51 Pre Filled Syringes 51 Mirapexin 51 Deferiprone 51 EUOBSERVER STRASBOURG 51 Receives Positive Opinion 51 Gene Therapy Advisory 51 IQWiG 51 Pirfenidone 51 Emission Trading Scheme 51 commissioner Janez Potocnik 51 olanzapine LAI 51 DG SANCO 51 see IP/#/# [002] 51 Glucomed 51 Directive #/#/EC amending 51 Cioloş 51 Innovative Medicines 51 bioequivalency 51 UNICRI 50 Roche MabThera 50 Orphan medicinal 50 Commissioner Gunter Verheugen 50 dual endothelin receptor antagonist 50 EU acquis 50 Morning Forex Overview 50 IORP Directive 50 trastuzumab DM1 50 Firdapse ™ amifampridine phosphate 50 Epo zeta 50 Takeover Directive 50 pemoline 50 Golimumab 50 IORP directive 50 Veterinary Medicines Directorate 50 Managers Directive 50 codecision procedure 50 Lipsovir ® 50 MEPACT 50 SCENIHR 50 WEEE Directives 50 Dalbavancin 50 reboxetine 50 gabapentin Neurontin 50 tolperisone 50 MS spasticity 50 theEU 50 Thalidomide Pharmion 50 non selective NSAIDs 50 Euratom treaty 50 Firazyr 50 Registration Evaluation Authorisation 50 CytoFab 50 CDSCO 50 6th Framework Programme 50 EU Directives 50 SVHCs 50 Regulatory Authority MHRA 50 Torisel temsirolimus 50 Enlarged Select 50 FLEG 50 EDCTP 50 Competence Assurance 50 see IP/#/# [001] 50 GTC recombinant human 50 Eli Lilly Cymbalta 50 Partnership EDCTP 50 Marie Curie Fellowship 50 Antigen CEA 50 Pronova 50 practices GMPs 50 INSPIRE Directive 50 CHMP recommendation 50 Commissioner Androulla Vassiliou 50 EDQM 50 HSNO Act 50 FDAAA 50 Advagraf 50 Hematological 50 CDISC standards 50 EFAMA 50 Preotact R 50 Tigecycline 50 Trobalt 50 Menaflex device 50 spokesman Pietro Petrucci 50 Commissioner McCreevy 50 Commissioner Philippe Busquin 50 Fundamental Rights FRA 50 Sycrest 50 IPPC Directive 50 Centre JRC 50 Integrated Pollution Prevention 50 Final Appraisal Determination 50 Coreper 50 Excessive Deficit Procedure 50 Nexavar sorafenib 50 Betaferon R 50 Nivestim 50 postmarketing adverse 50 Commissioner Siim Kallas 50 Transparency Directive 50 BESST 50 IVD CE 50 Amgen Prolia 50 Reinsurance Directive 50 spokeswoman Christiane Hohmann 50 Waste Framework Directive 50 Tysabri natalizumab 50 Plaquenil 50 Clinical Guideline 50 EU 50 injectable formulations 50 EPBD 50 Alvesco ® 50 Zelnorm Zelmac 50 Sanofi Aventis Acomplia 50 Temodal 50 Temsirolimus 50 Ahrenkilde Hansen 50 Abuse Directive 49 EuPC 49 nitrofuran 49 Romiplostim 49 antineoplastic 49 Regulatory Impact Assessment 49 scientifically substantiated 49 Tredaptive 49 CEFIC 49 Kiacta 49 Emission Trading Scheme ETS 49 Intensive Care Medicine 49 Data Retention Directive 49 Nitrates Directive 49 Exforge HCT 49 Mutual Recognition 49 Cipralex ® 49 Drug Approvals 49 Pre IND 49 aromatase inhibitors AIs 49 EEA EFTA 49 Bendamustine 49 thorough QT 49 Genzyme Myozyme 49 DG Sanco 49 PMPRB 49 MON# corn 49 Alitretinoin 49 spokesman Oliver Drewes 49 fusion enhancers 49 MAA submission 49 amending Directive #/#/EC 49 interinstitutional 49 Biosafety Protocol 49 FACTIVE tablets 49 Zometa zoledronic acid 49 commissioner Janez Potočnik 49 tocilizumab 49 rheumatoid arthritis sufferers 49 prasterone 49 Peginterferon alfa 2b 49 Progenta TM 49 Fondaparinux 49 Directives #/#/EC 49 eTEN 49 acyclovir Lauriad ® 49 EMCDDA 49 PPRS 49 Toctino ® 49 Marketing Authorisation Application 49 Waste Directive 49 Investigational Drugs 49 Operational Programmes 49 Antitumor 49 multidrug resistant bacteria 49 ecotoxicological 49 ASCEND HF 49 APVMA 49 Iressa gefitinib 49 AFSSAPS 49 TWYNSTA ® 49 safeguard clauses 49 CLL8 49 painkiller Prexige 49 Japanese Encephalitis vaccine 49 Time Directive EWTD 49 Omacor ® 49 #/#/EEC [001] 49 CE Marking 49 Arzerra ofatumumab 49 NIPs 49 Water Framework Directive 49 eCTD format 49 Warfarin Coumadin 49 rilonacept 49 Egrifta 49 GreenBuilding 49 Celebrex celecoxib 49 Amending Directive 49 Tyverb 49 Xarelto rivaroxaban 49 renal denervation 49 Bayer Onyx 49 Troxatyl TM 49 EFTA Surveillance Authority 49 Schengen acquis 49 Positive Opinion 49 Mr Bolkestein 49 nimesulide 49 Swissmedic 49 MDUFMA 49 ANVISA 49 UCITS Directive 49 Anti Bribery Convention 49 Control IPPC 49 Act FDAAA 49 EEA Agreement 49 Aarhus Convention 49 Artificial Cornea 49 codecision 49 Novartis Prexige 49 Menaflex implant 49 Circadin 49 Allowance EUA 49 EU Directive #/#/EC 49 Telecoms Package 49 Embosphere R 49 Emissions Trading System 49 Fully Covered Stent 49 INVOcell device 49 Waste Shipment 49 EuCIA 49 Desvenlafaxine 49 ELV Directive 49 TroVax ® 49 Tracleer ® 49 Fibrin Sealant Human 49 Renate Sommer 49 SAFLUTAN 49 cysteamine bitartrate 49 Mepact 49 SYCREST 49 CRD3 49 Basilea Toctino R 49 Directive #/#/EU 49 DG TREN 49 Anticoagulation 49 Erbitux cetuximab 49 biosafety protocol 49 leaf curling midge 49 NerPharMa 49 NOXAFIL 49 biostatistical analysis 49 TREDAPTIVE 49 Emission Trading System 49 Block Exemption 49 Organisation GPO 49 Veterinary Medicines Directorate VMD 49 Xyrem ® 49 Gram Sarker 48 Perindopril 48 Glivec imatinib 48 European Union 48 Spiriva HandiHaler 48 herbal medicinal 48 PKC isozymes 48 Velcade bortezomib 48 EPLA 48 transboundary movements 48 CRF antagonists 48 intravitreal implant 48 IPPP 48 Pertuzumab 48 methodologically rigorous 48 moxidectin 48 Femara letrozole 48 Botox Botox Cosmetic 48 Tumor Response 48 WIRB 48 Genetically Modified Organisms 48 Solidarity Fund EUSF 48 BYDUREON ™ 48 Essential Medicines List 48 primary dysmenorrhoea 48 Fundamental Rights Agency 48 7th Framework Programme 48 Cesr 48 CELVAPAN H#N# 48 Ecodesign Directive 48 SEA Directive 48 FDA Accelerated Approval 48 EP Plenary 48 developmental neurotoxicity 48 EuropaBio 48 Commissioner Kyprianou 48 WEEE RoHS 48 cinacalcet 48 Orphan Designation 48 Nikiforos Diamandouros 48 ISTODAX 48 Area SEPA 48 Temporary Framework 48 Eurodac 48 Therapeutic Goods 48 Gaucher Disease 48 spokesman Jens Mester 48 SA Asgi SA 48 Diagnostic Assay 48 Symbicort SMART 48 Greenhouse Gas Emissions Trading 48 ARV regimens 48 Rasilez HCT 48 Servier Laboratories 48 OMAPRO ™ 48 Evaluation Authorisation 48 Cardiac Outcomes 48 acquis communitaire 48 LEMS 48 human antithrombin 48 #/#/EEC [002] 48 ecodesign 48 Interpretative Communication 48 Sodium Injection 48 Revolade 48 Enlargement Commissioner Guenter Verheugen 48 biomarker identification 48 biosimilar versions 48 Standards CFATS 48 Cardiology ESC 48 IVDs 48 Expert Advisory Panel 48 ICNIRP guidelines 48 treating neuropathic pain 48 Pafuramidine 48 Freshfel 48 Gaydarski 48 ASPIRE HIGHER 48 Xenotransplantation 48 TENs 48 Europolitics 48 Subpart H 48 Commissioner Günther Oettinger 48 Civil Contingencies Bill 48 Securities Regulators CESR 48 virginiamycin 48 MabThera rituximab 48 Commissioner Mariann Fischer Boel 48 DIABECELL ® 48 Erythropoietic 48 Vandetanib 48 Cancidas 48 IP/#/# [002] 48 Waste Incineration Directive 48 econazole 48 Tracleer r 48 metabonomics 48 HCAI 48 BEXXAR therapeutic regimen 48 SAFENANO 48 HIF 1α 48 Anticoagulant 48 Pharmacovigilance 48 Bioequivalence 48 serological tests 48 Novartis Gilenia 48 TEQSA 48 Capital Requirements Directive 48 RhuDex 48 postmarket studies 48 Biosimilar 48 Tetrabenazine 48 AFSSA 48 JEOM 48 anti cholinesterase 48 Habitats Regulations 48 Patentability 48 Institut Jules Bordet 48 Larosiere 48 Services Directive PSD 48 horizontal overlaps 48 Rare Diseases 48 biotechnological inventions 48 Alogliptin 48 Ramazzini Foundation 48 central counterparties CCPs 48 EU Habitats Directive 48 BTWC 48 ERSPC 48 Immunosuppressant 48 ADVEXIN therapy 48 spokesman Gregor Kreuzhuber 48 Ambassador Erwan Fouere 48 Pharmacopoeia USP 48 OECD Anti Bribery 48 unilateral coercive 48 IGWG 48 REACH RoHS 48 FSAP 48 Toctino R 48 miconazole MBT 48 Alasdair Breckenridge 48 OvPlex 48 adeno associated viruses 48 vitro molecular diagnostic 48 NOC Regulations 48 ESHRE 48 Birds Directive 48 Bolkestein directive 48 Commissioner Potočnik 48 gepirone ER 48 Marketing Authorization Application 48 Colostrinin 48 commissioning PBC 48 Trandolapril 48 Commissioner Hammarberg 48 BfR 48 EUCD 48 Safe Harbor Framework 48 OCTs 48 Commissioner Stavros Dimas 48 Zelmac 48 Brilique 48 allergen labeling 48 bio prospecting 48 Thematic Strategy 48 NRAs 48 buccal spray 47 Candesartan 47 Pensions Regulator TPR 47 Cimzia ® certolizumab pegol 47 biologics FOBs 47 eMDR 47 GMO maize 47 Directive #/#/EC [005] 47 Myfortic 47 RoHS directives 47 Pesticide Testing 47 Accelerated Approval 47 CYP #D# 47 Angiox 47 Avastin bevacizumab 47 Lung Flute ® 47 NCCN guidelines 47 BioIndustry Association BIA 47 Environmental Impact Assessments 47 Packaging Waste 47 Genetically Modified Organisms GMO 47 Ladislav Miko 47 Cladribine 47 Lufthansa AUA 47 Czech Presidency 47 ZURICH AFX Novartis AG 47 Raptiva ® 47 EEG abnormalities 47 glatiramer 47 Global Rinderpest Eradication 47 EUREPGAP 47 HepaSphere 47 Mitigation Strategies REMS 47 JECFA 47 INVEGA ® 47 Zebinix 47 Angiox R 47 radionuclide therapy 47 Gonal f 47 CESCR 47 PbR 47 Eurovignette 47 Joint Undertaking 47 AECB 47 Yentreve ® 47 Trevor Mundel 47 nabilone 47 Ginkor Fort R 47 MHRA Medicines 47 Anidulafungin 47 Prexige lumiracoxib 47 somatostatin analogs 47 Roche Avastin 47 TNF alpha inhibitor 47 PRIPs 47 Autorité 47 Antiretroviral Therapy ART 47 Dasatinib 47 antibiotic Ketek 47 Europewide 47 BHIVA 47 Icatibant 47 EU acquis communautaire 47 EU directive #/#/EC 47 National Authorising Officer 47 Supplementary Protocol 47 Onbrez Breezhaler 47 intensive lipid lowering 47 unnecessarily duplicative 47 isoflavone supplement 47 RCEP 47 pioglitazone hydrochloride 47 Nitrates Action 47 Sanvar R 47 Letrozole 47 levocetirizine 47 prescribing beta blockers 47 TRIPs Agreement 47 Approvable 47 BCIRG 47 Vitro Diagnostic 47 derogations 47 ADME properties 47 Mycamine 47 Dankvert 47 Health Regulations IHR 47 Occupational Pensions Supervisors 47 Ahtisaari Plan 47 authority Gurian Sherman 47 Papadoulaki 47 poultrymeat 47 CE Marked 47 CARE HF 47 ß blockers 47 Commission Decision #/#/EC 47 Ecodesign 47 Schengen accord 47 ECAA 47 Oglemilast 47 prospective observational studies 47 Pesticide Residues 47 balsalazide tablet 47 Clinical Trial Investigating REOLYSIN 47 multimodality therapy 47 mediator Wolfgang Ischinger 47 EURATOM 47 Affairs Gergana Grancharova 47 ODSs 47 RoHS Directives 47 oral anticoagulation 47 POPRC 47 Commissioner Reding 47 efalizumab 47 Cosmetic Ingredient Review 47 antirheumatic 47 EWTD 47 Radiological Protection cites 47 ACCF AHA 47 Sebastian Sass 47 aripiprazole Abilify 47 Ozurdex 47 BAL# [002] 47 donepezil rivastigmine 47 Immunologic 47 Rectogesic 47 Xyzal ® 47 ESPAD 47 pharmacoeconomic 47 nitrofurantoin 47 antiangiogenic therapy 47 Pharmacopeial Convention 47 Multilateral Trade 47 Mitigation Strategies 47 Cariprazine 47 neuroleptic drugs 47 Proprietary Medicinal Products CPMP 47 Statutory Audit 47 Orazol 47 Dacogen injection 47 Zevalin consolidation 47 ERNA 47 Johannes Laitenberger 47 Pazopanib 47 Meta analyzes 47 Arixtra 47 stakeholder consultation 47 Ebixa 47 Lorne Hepworth 47 Cellcept 47 TNF inhibitor therapy 47 NICE SUGAR 47 SIEF 47 OSPAR 47 USDA NOP 47 MRLs 47 Adverse Event 47 Marinomed 47 Deca BDE 47 FATF Recommendations 47 GW# [003] 47 Seralini 47 Authority RQIA 47 Eurofound 47 Eurocodes 47 Microbicide Development 47 Brussels dtt net.com 47 intranasal corticosteroids 47 Bosutinib 47 Preotact 47 CAMR 47 AvMA 47 Premarket Approval 47 biosimilars 47 Liprotamase 47 antiepileptics 47 Essential Requirements 47 Ucits IV 47 Environmentally Sensitive Areas 47 EDPS 47 Schengen accession 47 GPASS 47 Teriparatide 47 RASFF 47 Organ Transplant Law 47 Eurobarometer surveys 47 Authorisation 47 Therapeutics Bulletin DTB 47 devicemakers 47 Regulatory Regime 47 Elocalcitol 47 Therapeutic Goods Administration TGA 47 Renal Cancer 47 Lymph node 47 PDOs 47 constipation OIC 47 Glucosamine chondroitin Arthritis 47 tests LDTs 47 generic biologic 47 Arthritis Drugs 47 antibacterial therapeutics 47 GURTs 47 Monitoring Mission EUMM 47 Dr. Roehrborn 47 Spiriva Handihaler 47 Grünenthal 47 Danube Strategy 47 genetically modified GMO crops 46 EchoCRT 46 EFSA 46 macrolide antibiotics 46 Azathioprine 46 Flutiform ™ 46 commissioner Meglena Kuneva 46 Best Practice Guidelines 46 IRESSA 46 Cefixime 46 Ozone Depleting Substances ODS 46 IPHA 46 Traditional Herbal 46 Smokefree Environments Act 46 DDT residues 46 Antonia Mochan 46 UCITS IV 46 spokeswoman Krisztina Nagy 46 occipital nerve stimulation 46 Acquis Communautaire 46 Tracleer R 46 BNetzA 46 FLEGT 46 ETSC 46 allergen avoidance 46 amifampridine phosphate 46 Amgen Nplate 46 Food Labelling 46 Inegy 46 Serbia Jelko Kacin 46 Torisel 46 Mycophenolate Mofetil 46 SIEFs 46 bio similars 46 multicentre study 46 PROactive study 46 levothyroxine sodium 46 Veterinary Medicines Authority 46 Adalimumab 46 NK# [001] 46 DVT prophylaxis 46 Resolor 46 antiplatelet medications 46 Metabolic Disorders 46 President Josep Borrell 46 Focetria 46 Genetic Therapies Directorate 46 Cartegena Protocol 46 anagrelide 46 GM oilseed rape 46 Severe Sepsis 46 macrolide antibiotic 46 NK# maize 46 ECJ judgment 46 Acta Scandinavica 46 REBETOL combination therapy 46 antibiotic residues 46 Basle II 46 EU Emission Trading 46 CDISC ODM 46 Artelon ® 46 UKIPO 46 RIGScan CR 46 hoFH 46 TheraSphere R 46 Neighbourhood Policy ENP 46 Process Analytical 46 Glenis Willmott 46 Current Controlled Trials 46 Subgroup analyzes 46 FDA Modernization Act 46 DAAs 46 Commissioner Busquin 46 REMINYL ® 46 Mejn 46 Rofecoxib 46 Robert Madelin 46 Stefaan De Rynck 46 Novartis Glivec 46 Covered Bond 46 Ropren 46 ICOB 46 MabCampath 46 PRIALT 46 Genetic Manipulation 46 cardiac repolarization 46 sublingual tablets 46 Alcohol Harm Reduction Strategy 46 Pfizer Sutent 46 Tesamorelin 46 Commissioner Margot Wallstrom 46 multicenter trials 46 Alastair Benbow 46 Ms Wallström 46 Asylum Procedures 46 Safety Authority EFSA 46 thorium utilization 46 Foundation ESF 46 Eli Lilly Alimta 46 STRASBOURG France Reuters 46 Fabry Disease 46 prospective multicentre 46 Proscribed Organizations Appeal 46 spokesman Lutz Guellner 46 spokesman Friso Roscam 46 folate fortification 46 combat IUU fishing 46 empirically validated 46 COMAH 46 elective percutaneous coronary 46 Pharmaceutical Industry ABPI 46 Europen Union 46 IGOs 46 RFMO 46 Ramelteon 46 cefuroxime axetil 46 Consumers Organisation BEUC 46 BPS IC 46 de Larosiere 46 F.D.A. 46 Interoperability Framework 46 Rosiglitazone 46 Diamyd ® 46 RoHS #/#/EC